EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Spatial-temporal lipidomics reveals dysregulated lipid metabolism in mouse brain during Alzheimer’s disease progression

Hongli Li, Zhihao Zhao, Lemei Zhu, Yejun Tan, Zheyu Zhang, Zhen Zhang, Jin Kang, Hongmei Lu, Weijun Peng, Qian Wu

Journal of Advanced Research · 2026-05 · 83 · 947-964

DOI: 10.1016/j.jare.2025.08.044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advanced Research, 2026-05. Verfasst von Hongli Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China…. Hauptthemen laut MEDLINE: Alzheimer Disease, Lipidomics, Lipid Metabolism, Brain. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, Hunan Provincial Natural Science Foundation, Science and Technology Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Tracking spatial lipidomic changes during Alzheimer's disease (AD) progression is crucial for elucidating the underlying mechanisms of the disease. OBJECTIVES: This study aims to investigate the spatial-temporal lipidomic alterations and their associated metabolic enzyme changes during AD progression. METHODS: The spatial lipidomic changes and corresponding alterations in metabolic enzymes during AD progression in amyloid precursor protein/presenilin-1 (APP/PS1) mice were thoroughly analyzed using an advanced ambient mass spectrometry imaging (MSI) technique, complemented by immunofluorescence (IF) imaging. RESULTS: Distinct lipidomic differences were observed between AD and wild-type (WT) mice in both the hippocampus (HP) and thalamus (TH), with the TH region exhibiting more significant lipid changes than the HP. A total of 88 lipid species with age- and region-specific alterations were identified, primarily within the sphingolipid, glycerolipid, and glycerophospholipid metabolic pathways. These metabolic changes were corroborated by IF imaging, which demonstrated spatial variations in the corresponding enzymes within the lipid metabolic pathways. Notably, a significant downregulation of hexosylceramides (HexCers) in the white matter of aged APP/PS1 mice suggests potential white matter abnormalities linked to AD. Correlation analysis further revealed that reduced HexCers were associated with the inhibited sulfatide-HexCer pathway, potentially driven by diminished ARSA levels, a factor known to be involved in microglial activation and inflammation. Additionally, upregulation of diacylglycerol (DG), observed even during the pre-symptomatic phase of AD, suggests DG as an early diagnostic biomarker. A strong correlation between the spatial changes in the DG-to-phosphatidylcholine (PC) ratio and phospholipase C (PLC) expression indicates that DG upregulation may result from PLC activation, a process known to be induced by amyloid β. CONCLUSIONS: This study provides an expanded spatial, temporal, and chemical perspective on AD mechanisms, offering potential avenues for enhancing early diagnosis and therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseLipidomicsLipid MetabolismBrainAnimalsMiceDisease ProgressionMice, TransgenicDisease Models, AnimalAmyloid beta-Protein PrecursorHippocampusMalePresenilin-1

Stichwörter der Autor:innen

Alzheimer’s diseaseAmbient mass spectrometry imagingGlycerolipid & glycerophospholipid metabolismSpatial lipidomicsSphingolipid metabolism

Substanzen

Amyloid beta-Protein PrecursorPresenilin-1

Autor:innen und Institutionen

  • Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; National Clinical Research Center for Mental Disorder, Changsha, Hun…
  • College of Chemistry and Chemical Engineering, Central South University, Changsha, Hunan 410083, China.
  • Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; Academician Workstation of Changsha Medical University, Changsha, Hu…
  • School of Mathematics, University of Minnesota Twin Cities, Minneapolis, MN 55455, United States.
  • YangSheng College of Traditional Chinese Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, China.
  • Department of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.

Förderung

  • China Postdoctoral Science Foundation
  • Hunan Provincial Natural Science Foundation
  • Science and Technology Program of Hunan Province
  • National Natural Science Foundation of China

Zitieren

APA

Li, H., Zhao, Z., Zhu, L., Tan, Y., Zhang, Z., Zhang, Z., Kang, J., Lu, H., Peng, W., & Wu, Q. (2026). Spatial-temporal lipidomics reveals dysregulated lipid metabolism in mouse brain during Alzheimer’s disease progression. Journal of Advanced Research, 83, 947-964. https://doi.org/10.1016/j.jare.2025.08.044

Vancouver

Li H, Zhao Z, Zhu L, Tan Y, Zhang Z, Zhang Z, et al. Spatial-temporal lipidomics reveals dysregulated lipid metabolism in mouse brain during Alzheimer’s disease progression. Journal of Advanced Research. 2026;83:947-964. doi:10.1016/j.jare.2025.08.044

BibTeX
@article{Li2026,
  author = {Li, Hongli and Zhao, Zhihao and Zhu, Lemei and Tan, Yejun and Zhang, Zheyu and Zhang, Zhen and Kang, Jin and Lu, Hongmei and Peng, Weijun and Wu, Qian},
  title = {Spatial-temporal lipidomics reveals dysregulated lipid metabolism in mouse brain during Alzheimer’s disease progression},
  journal = {Journal of Advanced Research},
  year = {2026},
  volume = {83},
  pages = {947--964},
  doi = {10.1016/j.jare.2025.08.044}
}
Kostenlos starten →